Vasoactive intestinal peptide potentiates sexual behavior: Inhibition by novel antagonist

Illana Gozes*, Eyal Meltzer, Sara Rubinrout, Douglas E. Brenneman, Mati Fridkin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Vasoactive intestinal peptide (VIP) has been suggested as a neurotransmitter mediating penile erection. We now show that VIP can stimulate sexual behavior in rats with reduced masculine potential due to pituitary grafting or castration. This effect was attenuated in the presence of a novel VIP antagonist, devised by a hybrid peptide strategy. Thus, we have synthesized a molecule combining a portion of VIP with a portion of neurotensin, peptides of opposite pharmacological action on cAMP formation and smooth muscle relaxation. The hybrid peptide markedly inhibited VIP’s effect on sexual behavior. This inhibition was manifested by a significant increase in the mean interval between copulatory events (> 3-fold change) coupled with a blockade of VIP-stimulated ejaculation. Other putative VIP antagonists were not as effective in blocking these activities. Thus, our results imply that VIP is not only associated with penile erection, but is involved in sexual behavior as well. Furthermore, the hybrid antagonist was shown to inhibit VIP binding in glial cell cultures. The availability of highly potent VIP antagonists may offer a route to study the possible multiple VIP receptors as well as help delineate other biological activities attributable to VIP.

Original languageEnglish
Pages (from-to)2945-2949
Number of pages5
Issue number6
StatePublished - Dec 1989
Externally publishedYes


Dive into the research topics of 'Vasoactive intestinal peptide potentiates sexual behavior: Inhibition by novel antagonist'. Together they form a unique fingerprint.

Cite this